Search abstracts

Aptamer anchored nano-architectures for treatment of drug resistant cancer

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: KESHARWANI, Prashant (Central Drug Research Institute, Lucknow, Pharmaceutics and Pharmacokinetics)
  • Co-author(s): Prashant Kesharwani
  • Abstract:


    Despite numerous advances in surgical treatment, chemotherapy and molecular 
    targeted agents for NSCLC, metastasis and multidrug resistance are still major causes for 
    failures in treating lung cancer patients
    . Thus, it is highly desirable to develop new therapeutic 
    approaches beyond conventional treatment for NSCLC



  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses